Can vitamin D metabolite measurements facilitate a “treat-to-target” paradigm to guide vitamin D supplementation? View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-01-09

AUTHORS

N. Binkley, J. Lappe, R. J. Singh, S. Khosla, D. Krueger, M. K. Drezner, R. D. Blank

ABSTRACT

Substantial variability exists in the serum 25(OH)D increase observed in response to vitamin D supplementation. Measurement of circulating cholecalciferol and 24,25(OH)2D, as indicators of vitamin D absorption and degradation, respectively, account for approximately half of the variation in serum 25(OH)D observed following supplementation.IntroductionVitamin D supplementation produces a variable response in serum 25(OH)D. This variability likely reflects, in part, differences in vitamin D absorption and/or degradation. Despite this variation in response, virtually all expert recommendations endorse a fixed vitamin D supplementation dose, an approach also used in most prospective studies. Such utilization of a single vitamin D dose does not assure attaining any pre-specified target 25(OH)D level, thereby compromising clinical care and prospective supplementation trials. This study begins addressing this weakness by exploring the feasibility of vitamin D metabolite measurements to predict serum 25(OH)D level attained following supplementation.MethodsNinety-one community-dwelling postmenopausal women with baseline 25(OH)D of 10–30 ng/mL received oral vitamin D3, 2300 or 2500 IU, daily for 4–6 months. Serum 25(OH)D, cholecalciferol (D3), and 24,25(OH)2D were measured before and at the end of supplementation to determine if metabolite concentrations allow prediction of the 25(OH)D level attained.ResultsFrom baseline and follow-up data, we derived a multiple linear regression model predicting posttreatment 25(OH)D as follows: final 25(OH)D = 8.3 + (1.05*initial 25(OH)D) − (7.7*initial 24,25(OH)2D) + (0.53*final D3) + (4.2*final 24,25(OH)2D). This model has an adjusted R2 = 0.55, thus accounting for approximately half of the observed variance in the final 25(OH)D level.ConclusionsThe contributions of circulating cholecalciferol and 24,25(OH)2D to this predictive model can be considered as indicators of intestinal absorption and clearance, respectively. This paradigm requires further study; it may allow efficient “treat-to-25(OH)D-target” strategies useful in optimizing prospective studies and clinical practice. More... »

PAGES

1655-1660

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00198-014-3010-0

DOI

http://dx.doi.org/10.1007/s00198-014-3010-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1016525284

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25572049


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "24,25-Dihydroxyvitamin D 3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Density Conservation Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholecalciferol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Supplements", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteoporosis, Postmenopausal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vitamin D", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Osteoporosis Clinical Research Program, University of Wisconsin, 2870 University Avenue, Suite 100, 53705, Madison, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.14003.36", 
          "name": [
            "Osteoporosis Clinical Research Program, University of Wisconsin, 2870 University Avenue, Suite 100, 53705, Madison, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Binkley", 
        "givenName": "N.", 
        "id": "sg:person.0762201325.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762201325.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Creighton University, Omaha, NE, USA", 
          "id": "http://www.grid.ac/institutes/grid.254748.8", 
          "name": [
            "Creighton University, Omaha, NE, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lappe", 
        "givenName": "J.", 
        "id": "sg:person.0714345342.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714345342.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Mayo Clinic, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Singh", 
        "givenName": "R. J.", 
        "id": "sg:person.013467616217.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013467616217.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mayo Clinic, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Mayo Clinic, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khosla", 
        "givenName": "S.", 
        "id": "sg:person.07365626717.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07365626717.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Osteoporosis Clinical Research Program, University of Wisconsin, 2870 University Avenue, Suite 100, 53705, Madison, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.14003.36", 
          "name": [
            "Osteoporosis Clinical Research Program, University of Wisconsin, 2870 University Avenue, Suite 100, 53705, Madison, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Krueger", 
        "givenName": "D.", 
        "id": "sg:person.01056220020.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056220020.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Osteoporosis Clinical Research Program, University of Wisconsin, 2870 University Avenue, Suite 100, 53705, Madison, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.14003.36", 
          "name": [
            "Osteoporosis Clinical Research Program, University of Wisconsin, 2870 University Avenue, Suite 100, 53705, Madison, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Drezner", 
        "givenName": "M. K.", 
        "id": "sg:person.01222421602.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222421602.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin, Milwaukee, WI, USA", 
          "id": "http://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Clement J Zablocki VAMC, Milwaukee, WI, USA", 
            "Medical College of Wisconsin, Milwaukee, WI, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blank", 
        "givenName": "R. D.", 
        "id": "sg:person.01045260424.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045260424.85"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2015-01-09", 
    "datePublishedReg": "2015-01-09", 
    "description": "Substantial variability exists in the serum 25(OH)D increase observed in response to vitamin D supplementation. Measurement of circulating cholecalciferol and 24,25(OH)2D, as indicators of vitamin D absorption and degradation, respectively, account for approximately half of the variation in serum 25(OH)D observed following supplementation.IntroductionVitamin D supplementation produces a variable response in serum 25(OH)D. This variability likely reflects, in part, differences in vitamin D absorption and/or degradation. Despite this variation in response, virtually all expert recommendations endorse a fixed vitamin D supplementation dose, an approach also used in most prospective studies. Such utilization of a single vitamin D dose does not assure attaining any pre-specified target 25(OH)D level, thereby compromising clinical care and prospective supplementation trials. This study begins addressing this weakness by exploring the feasibility of vitamin D metabolite measurements to predict serum 25(OH)D level attained following supplementation.MethodsNinety-one community-dwelling postmenopausal women with baseline 25(OH)D of 10\u201330\u00a0ng/mL received oral vitamin D3, 2300 or 2500\u00a0IU, daily for 4\u20136\u00a0months. Serum 25(OH)D, cholecalciferol (D3), and 24,25(OH)2D were measured before and at the end of supplementation to determine if metabolite concentrations allow prediction of the 25(OH)D level attained.ResultsFrom baseline and follow-up data, we derived a multiple linear regression model predicting posttreatment 25(OH)D as follows: final 25(OH)D\u2009=\u20098.3\u2009+\u2009(1.05*initial 25(OH)D) \u2212 (7.7*initial 24,25(OH)2D) + (0.53*final D3)\u2009+\u2009(4.2*final 24,25(OH)2D). This model has an adjusted R2\u2009=\u20090.55, thus accounting for approximately half of the observed variance in the final 25(OH)D level.ConclusionsThe contributions of circulating cholecalciferol and 24,25(OH)2D to this predictive model can be considered as indicators of intestinal absorption and clearance, respectively. This paradigm requires further study; it may allow efficient \u201ctreat-to-25(OH)D-target\u201d strategies useful in optimizing prospective studies and clinical practice.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00198-014-3010-0", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2464860", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2462448", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.3933774", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1100834", 
        "issn": [
          "0937-941X", 
          "1433-2965"
        ], 
        "name": "Osteoporosis International", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "vitamin D metabolite measurements", 
      "vitamin D supplementation", 
      "vitamin D absorption", 
      "D supplementation", 
      "prospective study", 
      "vitamin D supplementation dose", 
      "community-dwelling postmenopausal women", 
      "oral vitamin D3", 
      "vitamin D dose", 
      "most prospective studies", 
      "end of supplementation", 
      "ResultsFrom baseline", 
      "metabolite measurements", 
      "postmenopausal women", 
      "d dose", 
      "supplementation dose", 
      "supplementation trial", 
      "vitamin D3", 
      "clinical care", 
      "intestinal absorption", 
      "clinical practice", 
      "cholecalciferol", 
      "supplementation", 
      "expert recommendations", 
      "D absorption", 
      "metabolite concentrations", 
      "Further studies", 
      "linear regression models", 
      "dose", 
      "baseline", 
      "multiple linear regression model", 
      "regression models", 
      "variable response", 
      "substantial variability", 
      "response", 
      "levels", 
      "target", 
      "ConclusionsThe contribution", 
      "pre-specified target", 
      "IU", 
      "study", 
      "trials", 
      "serum", 
      "posttreatment", 
      "care", 
      "months", 
      "clearance", 
      "women", 
      "D3", 
      "half", 
      "treat", 
      "mL", 
      "predictive model", 
      "indicators", 
      "differences", 
      "recommendations", 
      "weakness", 
      "increase", 
      "variability", 
      "concentration", 
      "observed variance", 
      "such utilization", 
      "practice", 
      "absorption", 
      "data", 
      "strategies", 
      "feasibility", 
      "measurements", 
      "paradigm", 
      "model", 
      "utilization", 
      "end", 
      "variance", 
      "part", 
      "variation", 
      "degradation", 
      "approach", 
      "contribution", 
      "R2", 
      "prediction"
    ], 
    "name": "Can vitamin D metabolite measurements facilitate a \u201ctreat-to-target\u201d paradigm to guide vitamin D supplementation?", 
    "pagination": "1655-1660", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1016525284"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00198-014-3010-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25572049"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00198-014-3010-0", 
      "https://app.dimensions.ai/details/publication/pub.1016525284"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_654.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00198-014-3010-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-014-3010-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-014-3010-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-014-3010-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-014-3010-0'


 

This table displays all metadata directly associated to this object as RDF triples.

247 TRIPLES      20 PREDICATES      117 URIs      109 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00198-014-3010-0 schema:about N1104ead7334d4a168cc85aba6293347d
2 N21db1572d1204e71a098eb35f48c5579
3 N2f23f3c814864cf5a56d89feb9f92209
4 N6541a9515eb24667b27092dc30570703
5 N6774cf580c4740f0b2964568e9841836
6 N7bd06ef8293149e9bb0ea450124d156e
7 N8ef11e0a0c304a9697e051078f1e7b87
8 N99c2c6dc87f542f1821350b17518fc44
9 Nb1244bbfb1994d59a39ff68e61baefb7
10 Nc8cdcb589603437da049a69dd7ca5ffb
11 Ndaeac57e37a943f8aa3535bae371e620
12 Ne9ab50c986974b23a7620da664686cde
13 anzsrc-for:11
14 anzsrc-for:1103
15 schema:author N294fb686ac374a9185af4d4370de4ab4
16 schema:datePublished 2015-01-09
17 schema:datePublishedReg 2015-01-09
18 schema:description Substantial variability exists in the serum 25(OH)D increase observed in response to vitamin D supplementation. Measurement of circulating cholecalciferol and 24,25(OH)2D, as indicators of vitamin D absorption and degradation, respectively, account for approximately half of the variation in serum 25(OH)D observed following supplementation.IntroductionVitamin D supplementation produces a variable response in serum 25(OH)D. This variability likely reflects, in part, differences in vitamin D absorption and/or degradation. Despite this variation in response, virtually all expert recommendations endorse a fixed vitamin D supplementation dose, an approach also used in most prospective studies. Such utilization of a single vitamin D dose does not assure attaining any pre-specified target 25(OH)D level, thereby compromising clinical care and prospective supplementation trials. This study begins addressing this weakness by exploring the feasibility of vitamin D metabolite measurements to predict serum 25(OH)D level attained following supplementation.MethodsNinety-one community-dwelling postmenopausal women with baseline 25(OH)D of 10–30 ng/mL received oral vitamin D3, 2300 or 2500 IU, daily for 4–6 months. Serum 25(OH)D, cholecalciferol (D3), and 24,25(OH)2D were measured before and at the end of supplementation to determine if metabolite concentrations allow prediction of the 25(OH)D level attained.ResultsFrom baseline and follow-up data, we derived a multiple linear regression model predicting posttreatment 25(OH)D as follows: final 25(OH)D = 8.3 + (1.05*initial 25(OH)D) − (7.7*initial 24,25(OH)2D) + (0.53*final D3) + (4.2*final 24,25(OH)2D). This model has an adjusted R2 = 0.55, thus accounting for approximately half of the observed variance in the final 25(OH)D level.ConclusionsThe contributions of circulating cholecalciferol and 24,25(OH)2D to this predictive model can be considered as indicators of intestinal absorption and clearance, respectively. This paradigm requires further study; it may allow efficient “treat-to-25(OH)D-target” strategies useful in optimizing prospective studies and clinical practice.
19 schema:genre article
20 schema:isAccessibleForFree true
21 schema:isPartOf Nba34736e58c543b4930c80868feee4a3
22 Nc70b53099632463ab0d4a8073fe0402a
23 sg:journal.1100834
24 schema:keywords ConclusionsThe contribution
25 D absorption
26 D supplementation
27 D3
28 Further studies
29 IU
30 R2
31 ResultsFrom baseline
32 absorption
33 approach
34 baseline
35 care
36 cholecalciferol
37 clearance
38 clinical care
39 clinical practice
40 community-dwelling postmenopausal women
41 concentration
42 contribution
43 d dose
44 data
45 degradation
46 differences
47 dose
48 end
49 end of supplementation
50 expert recommendations
51 feasibility
52 half
53 increase
54 indicators
55 intestinal absorption
56 levels
57 linear regression models
58 mL
59 measurements
60 metabolite concentrations
61 metabolite measurements
62 model
63 months
64 most prospective studies
65 multiple linear regression model
66 observed variance
67 oral vitamin D3
68 paradigm
69 part
70 postmenopausal women
71 posttreatment
72 practice
73 pre-specified target
74 prediction
75 predictive model
76 prospective study
77 recommendations
78 regression models
79 response
80 serum
81 strategies
82 study
83 substantial variability
84 such utilization
85 supplementation
86 supplementation dose
87 supplementation trial
88 target
89 treat
90 trials
91 utilization
92 variability
93 variable response
94 variance
95 variation
96 vitamin D absorption
97 vitamin D dose
98 vitamin D metabolite measurements
99 vitamin D supplementation
100 vitamin D supplementation dose
101 vitamin D3
102 weakness
103 women
104 schema:name Can vitamin D metabolite measurements facilitate a “treat-to-target” paradigm to guide vitamin D supplementation?
105 schema:pagination 1655-1660
106 schema:productId N55a1abc787124f27842ed094f379cd57
107 N99b3ae4824d6417ebc1bb04f28679ad8
108 Ne11f44409486473ca97b68710b3a6a18
109 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016525284
110 https://doi.org/10.1007/s00198-014-3010-0
111 schema:sdDatePublished 2022-11-24T20:58
112 schema:sdLicense https://scigraph.springernature.com/explorer/license/
113 schema:sdPublisher N1d744d920f314d48b52e2f653ab2d074
114 schema:url https://doi.org/10.1007/s00198-014-3010-0
115 sgo:license sg:explorer/license/
116 sgo:sdDataset articles
117 rdf:type schema:ScholarlyArticle
118 N1104ead7334d4a168cc85aba6293347d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Humans
120 rdf:type schema:DefinedTerm
121 N1d744d920f314d48b52e2f653ab2d074 schema:name Springer Nature - SN SciGraph project
122 rdf:type schema:Organization
123 N21db1572d1204e71a098eb35f48c5579 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Osteoporosis, Postmenopausal
125 rdf:type schema:DefinedTerm
126 N294fb686ac374a9185af4d4370de4ab4 rdf:first sg:person.0762201325.44
127 rdf:rest N395949d7033a41f2b805e1db22b3c815
128 N2f23f3c814864cf5a56d89feb9f92209 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Dietary Supplements
130 rdf:type schema:DefinedTerm
131 N35c019af174e46e9a1f47dffac955b51 rdf:first sg:person.01056220020.44
132 rdf:rest Nf650736309a34fecb3ad971abfb53488
133 N395949d7033a41f2b805e1db22b3c815 rdf:first sg:person.0714345342.23
134 rdf:rest N90a60061027e4194806feb50c16b82c7
135 N55a1abc787124f27842ed094f379cd57 schema:name doi
136 schema:value 10.1007/s00198-014-3010-0
137 rdf:type schema:PropertyValue
138 N6541a9515eb24667b27092dc30570703 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Follow-Up Studies
140 rdf:type schema:DefinedTerm
141 N6774cf580c4740f0b2964568e9841836 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Drug Monitoring
143 rdf:type schema:DefinedTerm
144 N67e142eb74a149cd91ca17907375883a rdf:first sg:person.07365626717.38
145 rdf:rest N35c019af174e46e9a1f47dffac955b51
146 N7bd06ef8293149e9bb0ea450124d156e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Female
148 rdf:type schema:DefinedTerm
149 N8ef11e0a0c304a9697e051078f1e7b87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Cholecalciferol
151 rdf:type schema:DefinedTerm
152 N90a60061027e4194806feb50c16b82c7 rdf:first sg:person.013467616217.01
153 rdf:rest N67e142eb74a149cd91ca17907375883a
154 N99b3ae4824d6417ebc1bb04f28679ad8 schema:name dimensions_id
155 schema:value pub.1016525284
156 rdf:type schema:PropertyValue
157 N99c2c6dc87f542f1821350b17518fc44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Vitamin D
159 rdf:type schema:DefinedTerm
160 Na832f61c10c0474f94d6219d2bfdbd73 rdf:first sg:person.01045260424.85
161 rdf:rest rdf:nil
162 Nb1244bbfb1994d59a39ff68e61baefb7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Middle Aged
164 rdf:type schema:DefinedTerm
165 Nba34736e58c543b4930c80868feee4a3 schema:volumeNumber 26
166 rdf:type schema:PublicationVolume
167 Nc70b53099632463ab0d4a8073fe0402a schema:issueNumber 5
168 rdf:type schema:PublicationIssue
169 Nc8cdcb589603437da049a69dd7ca5ffb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Aged
171 rdf:type schema:DefinedTerm
172 Ndaeac57e37a943f8aa3535bae371e620 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Bone Density Conservation Agents
174 rdf:type schema:DefinedTerm
175 Ne11f44409486473ca97b68710b3a6a18 schema:name pubmed_id
176 schema:value 25572049
177 rdf:type schema:PropertyValue
178 Ne9ab50c986974b23a7620da664686cde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name 24,25-Dihydroxyvitamin D 3
180 rdf:type schema:DefinedTerm
181 Nf650736309a34fecb3ad971abfb53488 rdf:first sg:person.01222421602.94
182 rdf:rest Na832f61c10c0474f94d6219d2bfdbd73
183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
184 schema:name Medical and Health Sciences
185 rdf:type schema:DefinedTerm
186 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
187 schema:name Clinical Sciences
188 rdf:type schema:DefinedTerm
189 sg:grant.2462448 http://pending.schema.org/fundedItem sg:pub.10.1007/s00198-014-3010-0
190 rdf:type schema:MonetaryGrant
191 sg:grant.2464860 http://pending.schema.org/fundedItem sg:pub.10.1007/s00198-014-3010-0
192 rdf:type schema:MonetaryGrant
193 sg:grant.3933774 http://pending.schema.org/fundedItem sg:pub.10.1007/s00198-014-3010-0
194 rdf:type schema:MonetaryGrant
195 sg:journal.1100834 schema:issn 0937-941X
196 1433-2965
197 schema:name Osteoporosis International
198 schema:publisher Springer Nature
199 rdf:type schema:Periodical
200 sg:person.01045260424.85 schema:affiliation grid-institutes:grid.30760.32
201 schema:familyName Blank
202 schema:givenName R. D.
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045260424.85
204 rdf:type schema:Person
205 sg:person.01056220020.44 schema:affiliation grid-institutes:grid.14003.36
206 schema:familyName Krueger
207 schema:givenName D.
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056220020.44
209 rdf:type schema:Person
210 sg:person.01222421602.94 schema:affiliation grid-institutes:grid.14003.36
211 schema:familyName Drezner
212 schema:givenName M. K.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222421602.94
214 rdf:type schema:Person
215 sg:person.013467616217.01 schema:affiliation grid-institutes:grid.66875.3a
216 schema:familyName Singh
217 schema:givenName R. J.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013467616217.01
219 rdf:type schema:Person
220 sg:person.0714345342.23 schema:affiliation grid-institutes:grid.254748.8
221 schema:familyName Lappe
222 schema:givenName J.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0714345342.23
224 rdf:type schema:Person
225 sg:person.07365626717.38 schema:affiliation grid-institutes:grid.66875.3a
226 schema:familyName Khosla
227 schema:givenName S.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07365626717.38
229 rdf:type schema:Person
230 sg:person.0762201325.44 schema:affiliation grid-institutes:grid.14003.36
231 schema:familyName Binkley
232 schema:givenName N.
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0762201325.44
234 rdf:type schema:Person
235 grid-institutes:grid.14003.36 schema:alternateName Osteoporosis Clinical Research Program, University of Wisconsin, 2870 University Avenue, Suite 100, 53705, Madison, WI, USA
236 schema:name Osteoporosis Clinical Research Program, University of Wisconsin, 2870 University Avenue, Suite 100, 53705, Madison, WI, USA
237 rdf:type schema:Organization
238 grid-institutes:grid.254748.8 schema:alternateName Creighton University, Omaha, NE, USA
239 schema:name Creighton University, Omaha, NE, USA
240 rdf:type schema:Organization
241 grid-institutes:grid.30760.32 schema:alternateName Medical College of Wisconsin, Milwaukee, WI, USA
242 schema:name Clement J Zablocki VAMC, Milwaukee, WI, USA
243 Medical College of Wisconsin, Milwaukee, WI, USA
244 rdf:type schema:Organization
245 grid-institutes:grid.66875.3a schema:alternateName Mayo Clinic, Rochester, MN, USA
246 schema:name Mayo Clinic, Rochester, MN, USA
247 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...